Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Philips Buys Heart Imaging Tech Firm Set Up By Biosense Founder

Executive Summary

Philips is bulking-up its image-guided therapy portfolio with the acquisition of EPD Solutions, which has a recently CE-marked cardiac imaging and navigation system for ablation procedures to treat heart arrhythmias. EPD was founded by serial inventor and entrepreneur, Shlomo Ben-Haim, the man behind Johnson & Johnson's Biosense Webster business. 

You may also be interested in...

M&A Analysis: Dealmaking Simmers In June

Medtech M&A activity waned in June, with the market showing signs of a summer slump. Twelve acquisitions were announced and closed during the month, a dip in activity compared to the 21 deals recorded in the same period last year, and the 17 recorded in May.

M&A Analysis – Acquisitions Come What May

The steady flow of medtech M&A deal-making continued in May; Medtech Insight recorded 16 acquisitions last month, including a global merger of Sivantos and Widex to form the world's third-largest hearing-aid company, ready to challenge market leaders Sonova and William Demant.

Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?

Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.


Related Companies

Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts